Loading…
Neutrophils, Cancer and Thrombosis: The New Bermuda Triangle in Cancer Research
Spontaneous venous thrombosis is often the first clinical sign of cancer, and it is linked to a worsened survival rate. Traditionally, tumor-cell induced platelet activation has been the main actor studied in cancer-associated-thrombosis. However, platelet involvement alone does not seem to be suffi...
Saved in:
Published in: | International journal of molecular sciences 2022-01, Vol.23 (3), p.1257 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c578t-475fd0709022db869b00606c9c7137a0b6abe55e77baebbb8c3affef9790e143 |
---|---|
cites | cdi_FETCH-LOGICAL-c578t-475fd0709022db869b00606c9c7137a0b6abe55e77baebbb8c3affef9790e143 |
container_end_page | |
container_issue | 3 |
container_start_page | 1257 |
container_title | International journal of molecular sciences |
container_volume | 23 |
creator | Langiu, Mélanie Palacios-Acedo, Ana-Luisa Crescence, Lydie Mege, Diane Dubois, Christophe Panicot-Dubois, Laurence |
description | Spontaneous venous thrombosis is often the first clinical sign of cancer, and it is linked to a worsened survival rate. Traditionally, tumor-cell induced platelet activation has been the main actor studied in cancer-associated-thrombosis. However, platelet involvement alone does not seem to be sufficient to explain this heightened pro-thrombotic state. Neutrophils are emerging as key players in both thrombus generation and cancer progression. Neutrophils can impact thrombosis through the release of pro-inflammatory cytokines and expression of molecules like P-selectin and Tissue Factor (TF) on their membrane and on neutrophil-derived microvesicles. Their role in cancer progression is evidenced by the fact that patients with high blood-neutrophil counts have a worsened prognosis. Tumors can attract neutrophils to the cancer site via pro-inflammatory cytokine secretions and induce a switch to pro-tumoral (or N2) neutrophils, which support metastatic spread and have an immunosuppressive role. They can also expel their nuclear contents to entrap pathogens forming Neutrophil Extracellular Traps (NETs) and can also capture coagulation factors, enhancing the thrombus formation. These NETs are also known to have pro-tumoral effects by supporting the metastatic process. Here, we strived to do a comprehensive literature review of the role of neutrophils as drivers of both cancer-associated thrombosis (CAT) and cancer progression. |
doi_str_mv | 10.3390/ijms23031257 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_26fa379f35f643c3b4af68c1b24d63dd</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_26fa379f35f643c3b4af68c1b24d63dd</doaj_id><sourcerecordid>2629057667</sourcerecordid><originalsourceid>FETCH-LOGICAL-c578t-475fd0709022db869b00606c9c7137a0b6abe55e77baebbb8c3affef9790e143</originalsourceid><addsrcrecordid>eNpdkt1rFDEUxQdRbK2--SwDvih0NR-TLx-EuqgtLC3Ivockc7OTZWayJjMV_3uzblu2fcrl5nfPPQmnqt5i9IlShT6H7ZAJRRQTJp5Vp7ghZIEQF8-P6pPqVc5bhAglTL2sTijDnGKJTquba5inFHdd6PN5vTSjg1Sbsa3XXYqDjTnkL6WG-hr-1N8gDXNr6nUKZtz0UIfxfuQXZDDJda-rF970Gd7cnWfV-sf39fJysbr5ebW8WC0cE3JaNIL5FgmkECGtlVzZYhNxp5zAVBhkubHAGAhhDVhrpaPGe_BKKAS4oWfV1UG2jWardykMJv3V0QT9vxHTRps0BdeDJtwbKpSnzPOGOmob47l02JKm5bRti9bXg9ZutgO0DsYpmf6R6OObMXR6E2-1lJRjjorAx4NA92Ts8mKl9z1EuWRS0Vtc2A93y1L8PUOe9BCyg743I8Q5F7dEISY4FwV9_wTdxjmN5Vf3lBBIiIYU6vxAuRRzTuAfHGCk9wHRxwEp-Lvjxz7A94mg_wCrdrVA</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2627707742</pqid></control><display><type>article</type><title>Neutrophils, Cancer and Thrombosis: The New Bermuda Triangle in Cancer Research</title><source>PubMed (Medline)</source><source>Publicly Available Content Database</source><creator>Langiu, Mélanie ; Palacios-Acedo, Ana-Luisa ; Crescence, Lydie ; Mege, Diane ; Dubois, Christophe ; Panicot-Dubois, Laurence</creator><creatorcontrib>Langiu, Mélanie ; Palacios-Acedo, Ana-Luisa ; Crescence, Lydie ; Mege, Diane ; Dubois, Christophe ; Panicot-Dubois, Laurence</creatorcontrib><description>Spontaneous venous thrombosis is often the first clinical sign of cancer, and it is linked to a worsened survival rate. Traditionally, tumor-cell induced platelet activation has been the main actor studied in cancer-associated-thrombosis. However, platelet involvement alone does not seem to be sufficient to explain this heightened pro-thrombotic state. Neutrophils are emerging as key players in both thrombus generation and cancer progression. Neutrophils can impact thrombosis through the release of pro-inflammatory cytokines and expression of molecules like P-selectin and Tissue Factor (TF) on their membrane and on neutrophil-derived microvesicles. Their role in cancer progression is evidenced by the fact that patients with high blood-neutrophil counts have a worsened prognosis. Tumors can attract neutrophils to the cancer site via pro-inflammatory cytokine secretions and induce a switch to pro-tumoral (or N2) neutrophils, which support metastatic spread and have an immunosuppressive role. They can also expel their nuclear contents to entrap pathogens forming Neutrophil Extracellular Traps (NETs) and can also capture coagulation factors, enhancing the thrombus formation. These NETs are also known to have pro-tumoral effects by supporting the metastatic process. Here, we strived to do a comprehensive literature review of the role of neutrophils as drivers of both cancer-associated thrombosis (CAT) and cancer progression.</description><identifier>ISSN: 1422-0067</identifier><identifier>ISSN: 1661-6596</identifier><identifier>EISSN: 1422-0067</identifier><identifier>DOI: 10.3390/ijms23031257</identifier><identifier>PMID: 35163180</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Blood clots ; Blood Platelets - metabolism ; Cancer ; Cancer research ; Cell activation ; Coagulation ; Cytokines ; Endothelium ; Extracellular Traps - metabolism ; Growth factors ; Humans ; Inflammation ; Lasers ; Leukocytes (neutrophilic) ; Life Sciences ; Literature reviews ; Medical prognosis ; Metastases ; Neoplasms - immunology ; Neoplasms - metabolism ; NET ; neutrophil ; Neutrophils ; Neutrophils - immunology ; Neutrophils - metabolism ; P-selectin ; P-Selectin - metabolism ; Pathogens ; Platelet Activation - immunology ; Platelet Activation - physiology ; Review ; Secretions ; Thromboplastin - metabolism ; Thrombosis ; Thrombosis - immunology ; Thrombosis - metabolism ; Tissue factor ; Tumors ; Venous Thrombosis - metabolism</subject><ispartof>International journal of molecular sciences, 2022-01, Vol.23 (3), p.1257</ispartof><rights>2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Attribution</rights><rights>2022 by the authors. 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c578t-475fd0709022db869b00606c9c7137a0b6abe55e77baebbb8c3affef9790e143</citedby><cites>FETCH-LOGICAL-c578t-475fd0709022db869b00606c9c7137a0b6abe55e77baebbb8c3affef9790e143</cites><orcidid>0000-0003-0848-5009 ; 0000-0003-2421-6087 ; 0000-0002-3468-8435</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2627707742/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2627707742?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35163180$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-03685893$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Langiu, Mélanie</creatorcontrib><creatorcontrib>Palacios-Acedo, Ana-Luisa</creatorcontrib><creatorcontrib>Crescence, Lydie</creatorcontrib><creatorcontrib>Mege, Diane</creatorcontrib><creatorcontrib>Dubois, Christophe</creatorcontrib><creatorcontrib>Panicot-Dubois, Laurence</creatorcontrib><title>Neutrophils, Cancer and Thrombosis: The New Bermuda Triangle in Cancer Research</title><title>International journal of molecular sciences</title><addtitle>Int J Mol Sci</addtitle><description>Spontaneous venous thrombosis is often the first clinical sign of cancer, and it is linked to a worsened survival rate. Traditionally, tumor-cell induced platelet activation has been the main actor studied in cancer-associated-thrombosis. However, platelet involvement alone does not seem to be sufficient to explain this heightened pro-thrombotic state. Neutrophils are emerging as key players in both thrombus generation and cancer progression. Neutrophils can impact thrombosis through the release of pro-inflammatory cytokines and expression of molecules like P-selectin and Tissue Factor (TF) on their membrane and on neutrophil-derived microvesicles. Their role in cancer progression is evidenced by the fact that patients with high blood-neutrophil counts have a worsened prognosis. Tumors can attract neutrophils to the cancer site via pro-inflammatory cytokine secretions and induce a switch to pro-tumoral (or N2) neutrophils, which support metastatic spread and have an immunosuppressive role. They can also expel their nuclear contents to entrap pathogens forming Neutrophil Extracellular Traps (NETs) and can also capture coagulation factors, enhancing the thrombus formation. These NETs are also known to have pro-tumoral effects by supporting the metastatic process. Here, we strived to do a comprehensive literature review of the role of neutrophils as drivers of both cancer-associated thrombosis (CAT) and cancer progression.</description><subject>Blood clots</subject><subject>Blood Platelets - metabolism</subject><subject>Cancer</subject><subject>Cancer research</subject><subject>Cell activation</subject><subject>Coagulation</subject><subject>Cytokines</subject><subject>Endothelium</subject><subject>Extracellular Traps - metabolism</subject><subject>Growth factors</subject><subject>Humans</subject><subject>Inflammation</subject><subject>Lasers</subject><subject>Leukocytes (neutrophilic)</subject><subject>Life Sciences</subject><subject>Literature reviews</subject><subject>Medical prognosis</subject><subject>Metastases</subject><subject>Neoplasms - immunology</subject><subject>Neoplasms - metabolism</subject><subject>NET</subject><subject>neutrophil</subject><subject>Neutrophils</subject><subject>Neutrophils - immunology</subject><subject>Neutrophils - metabolism</subject><subject>P-selectin</subject><subject>P-Selectin - metabolism</subject><subject>Pathogens</subject><subject>Platelet Activation - immunology</subject><subject>Platelet Activation - physiology</subject><subject>Review</subject><subject>Secretions</subject><subject>Thromboplastin - metabolism</subject><subject>Thrombosis</subject><subject>Thrombosis - immunology</subject><subject>Thrombosis - metabolism</subject><subject>Tissue factor</subject><subject>Tumors</subject><subject>Venous Thrombosis - metabolism</subject><issn>1422-0067</issn><issn>1661-6596</issn><issn>1422-0067</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNpdkt1rFDEUxQdRbK2--SwDvih0NR-TLx-EuqgtLC3Ivockc7OTZWayJjMV_3uzblu2fcrl5nfPPQmnqt5i9IlShT6H7ZAJRRQTJp5Vp7ghZIEQF8-P6pPqVc5bhAglTL2sTijDnGKJTquba5inFHdd6PN5vTSjg1Sbsa3XXYqDjTnkL6WG-hr-1N8gDXNr6nUKZtz0UIfxfuQXZDDJda-rF970Gd7cnWfV-sf39fJysbr5ebW8WC0cE3JaNIL5FgmkECGtlVzZYhNxp5zAVBhkubHAGAhhDVhrpaPGe_BKKAS4oWfV1UG2jWardykMJv3V0QT9vxHTRps0BdeDJtwbKpSnzPOGOmob47l02JKm5bRti9bXg9ZutgO0DsYpmf6R6OObMXR6E2-1lJRjjorAx4NA92Ts8mKl9z1EuWRS0Vtc2A93y1L8PUOe9BCyg743I8Q5F7dEISY4FwV9_wTdxjmN5Vf3lBBIiIYU6vxAuRRzTuAfHGCk9wHRxwEp-Lvjxz7A94mg_wCrdrVA</recordid><startdate>20220123</startdate><enddate>20220123</enddate><creator>Langiu, Mélanie</creator><creator>Palacios-Acedo, Ana-Luisa</creator><creator>Crescence, Lydie</creator><creator>Mege, Diane</creator><creator>Dubois, Christophe</creator><creator>Panicot-Dubois, Laurence</creator><general>MDPI AG</general><general>MDPI</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>1XC</scope><scope>VOOES</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0003-0848-5009</orcidid><orcidid>https://orcid.org/0000-0003-2421-6087</orcidid><orcidid>https://orcid.org/0000-0002-3468-8435</orcidid></search><sort><creationdate>20220123</creationdate><title>Neutrophils, Cancer and Thrombosis: The New Bermuda Triangle in Cancer Research</title><author>Langiu, Mélanie ; Palacios-Acedo, Ana-Luisa ; Crescence, Lydie ; Mege, Diane ; Dubois, Christophe ; Panicot-Dubois, Laurence</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c578t-475fd0709022db869b00606c9c7137a0b6abe55e77baebbb8c3affef9790e143</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Blood clots</topic><topic>Blood Platelets - metabolism</topic><topic>Cancer</topic><topic>Cancer research</topic><topic>Cell activation</topic><topic>Coagulation</topic><topic>Cytokines</topic><topic>Endothelium</topic><topic>Extracellular Traps - metabolism</topic><topic>Growth factors</topic><topic>Humans</topic><topic>Inflammation</topic><topic>Lasers</topic><topic>Leukocytes (neutrophilic)</topic><topic>Life Sciences</topic><topic>Literature reviews</topic><topic>Medical prognosis</topic><topic>Metastases</topic><topic>Neoplasms - immunology</topic><topic>Neoplasms - metabolism</topic><topic>NET</topic><topic>neutrophil</topic><topic>Neutrophils</topic><topic>Neutrophils - immunology</topic><topic>Neutrophils - metabolism</topic><topic>P-selectin</topic><topic>P-Selectin - metabolism</topic><topic>Pathogens</topic><topic>Platelet Activation - immunology</topic><topic>Platelet Activation - physiology</topic><topic>Review</topic><topic>Secretions</topic><topic>Thromboplastin - metabolism</topic><topic>Thrombosis</topic><topic>Thrombosis - immunology</topic><topic>Thrombosis - metabolism</topic><topic>Tissue factor</topic><topic>Tumors</topic><topic>Venous Thrombosis - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Langiu, Mélanie</creatorcontrib><creatorcontrib>Palacios-Acedo, Ana-Luisa</creatorcontrib><creatorcontrib>Crescence, Lydie</creatorcontrib><creatorcontrib>Mege, Diane</creatorcontrib><creatorcontrib>Dubois, Christophe</creatorcontrib><creatorcontrib>Panicot-Dubois, Laurence</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest research library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>Hyper Article en Ligne (HAL) (Open Access)</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>International journal of molecular sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Langiu, Mélanie</au><au>Palacios-Acedo, Ana-Luisa</au><au>Crescence, Lydie</au><au>Mege, Diane</au><au>Dubois, Christophe</au><au>Panicot-Dubois, Laurence</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Neutrophils, Cancer and Thrombosis: The New Bermuda Triangle in Cancer Research</atitle><jtitle>International journal of molecular sciences</jtitle><addtitle>Int J Mol Sci</addtitle><date>2022-01-23</date><risdate>2022</risdate><volume>23</volume><issue>3</issue><spage>1257</spage><pages>1257-</pages><issn>1422-0067</issn><issn>1661-6596</issn><eissn>1422-0067</eissn><abstract>Spontaneous venous thrombosis is often the first clinical sign of cancer, and it is linked to a worsened survival rate. Traditionally, tumor-cell induced platelet activation has been the main actor studied in cancer-associated-thrombosis. However, platelet involvement alone does not seem to be sufficient to explain this heightened pro-thrombotic state. Neutrophils are emerging as key players in both thrombus generation and cancer progression. Neutrophils can impact thrombosis through the release of pro-inflammatory cytokines and expression of molecules like P-selectin and Tissue Factor (TF) on their membrane and on neutrophil-derived microvesicles. Their role in cancer progression is evidenced by the fact that patients with high blood-neutrophil counts have a worsened prognosis. Tumors can attract neutrophils to the cancer site via pro-inflammatory cytokine secretions and induce a switch to pro-tumoral (or N2) neutrophils, which support metastatic spread and have an immunosuppressive role. They can also expel their nuclear contents to entrap pathogens forming Neutrophil Extracellular Traps (NETs) and can also capture coagulation factors, enhancing the thrombus formation. These NETs are also known to have pro-tumoral effects by supporting the metastatic process. Here, we strived to do a comprehensive literature review of the role of neutrophils as drivers of both cancer-associated thrombosis (CAT) and cancer progression.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>35163180</pmid><doi>10.3390/ijms23031257</doi><orcidid>https://orcid.org/0000-0003-0848-5009</orcidid><orcidid>https://orcid.org/0000-0003-2421-6087</orcidid><orcidid>https://orcid.org/0000-0002-3468-8435</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1422-0067 |
ispartof | International journal of molecular sciences, 2022-01, Vol.23 (3), p.1257 |
issn | 1422-0067 1661-6596 1422-0067 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_26fa379f35f643c3b4af68c1b24d63dd |
source | PubMed (Medline); Publicly Available Content Database |
subjects | Blood clots Blood Platelets - metabolism Cancer Cancer research Cell activation Coagulation Cytokines Endothelium Extracellular Traps - metabolism Growth factors Humans Inflammation Lasers Leukocytes (neutrophilic) Life Sciences Literature reviews Medical prognosis Metastases Neoplasms - immunology Neoplasms - metabolism NET neutrophil Neutrophils Neutrophils - immunology Neutrophils - metabolism P-selectin P-Selectin - metabolism Pathogens Platelet Activation - immunology Platelet Activation - physiology Review Secretions Thromboplastin - metabolism Thrombosis Thrombosis - immunology Thrombosis - metabolism Tissue factor Tumors Venous Thrombosis - metabolism |
title | Neutrophils, Cancer and Thrombosis: The New Bermuda Triangle in Cancer Research |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T21%3A26%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Neutrophils,%20Cancer%20and%20Thrombosis:%20The%20New%20Bermuda%20Triangle%20in%20Cancer%20Research&rft.jtitle=International%20journal%20of%20molecular%20sciences&rft.au=Langiu,%20M%C3%A9lanie&rft.date=2022-01-23&rft.volume=23&rft.issue=3&rft.spage=1257&rft.pages=1257-&rft.issn=1422-0067&rft.eissn=1422-0067&rft_id=info:doi/10.3390/ijms23031257&rft_dat=%3Cproquest_doaj_%3E2629057667%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c578t-475fd0709022db869b00606c9c7137a0b6abe55e77baebbb8c3affef9790e143%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2627707742&rft_id=info:pmid/35163180&rfr_iscdi=true |